Farms.com Home   Farm Equipment News

John Deere Settles Foreign Bribery Case with $9.9 Million Agreement

Deere & Company has agreed to pay $9.9 million to settle charges from the Security and Exchange Commission alleging that the company violated the Foreign Corrupt Practices Act, which prohibits U.S. companies from paying foreign government officials to aid in acquiring business.

The SEC concluded that Deere was in violation of the FCPA's record keeping policies and Deere & Company agreed to the SEC's order to cease and desist from further violations of the FCPA. The $9.9 million is a result of 2 separate payments — $5.4 million which the company is alleged to have profited from the scandal as well as $4.5 million in additional civil penalties. 

Despite calls from various organizations for top Deere officials to resign, the terms of the $9.9 million settlement do not include any acknowledgement of fault or denial of guilt from Deere.   

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.